Insili Smart announced on August 20 that it has officially reached a research and development cooperation with Yuancode Intelligent Pharmaceutical, which focuses on the development of next-generation RNA innovative drugs. The two sides will focus on AI new antigen prediction and sequence design, cyclic mRNA, targeted delivery, automated experiments, and intelligent manufacturing to jointly build a next-generation mRNA AI native R&D engine to explore individualized tumor vaccines and related innovative therapies.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.